Turner Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-23,000
Closed -$1.27M 217
2016
Q2
$1.27M Sell
23,000
-14,000
-38% -$771K 0.4% 76
2016
Q1
$1.98M Sell
37,000
-26,000
-41% -$1.28M 0.54% 63
2015
Q4
$3.24M Buy
63,000
+16,650
+36% +$827K 0.67% 55
2015
Q3
$2.09M Buy
46,350
+3,010
+7% +$142K 0.42% 81
2015
Q2
$2M Buy
+43,340
New +$1.9M 0.37% 92
2014
Q1
Sell
-333,650
Closed -$11.9M 696
2013
Q4
$11.9M Sell
333,650
-50,060
-13% -$1.66M 0.21% 152
2013
Q3
$11.6M Buy
383,710
+341,940
+819% +$11.2M 0.19% 172
2013
Q2
$1.22M Buy
+41,770
New +$1.18M 0.02% 488

Other funds holding PBH

Turner Investments's PBH Position: Q3 2016 in Review

Turner Investments sold out of Prestige Consumer Healthcare (PBH) in Q3 2016, closing a stake of 23,000 shares — an estimated $1.27M sold.

Turner Investments first reported a position in PBH in Q2 2013 and held it in 8 quarters. The position peaked at $11.9M in Q4 2013. 243 funds tracked by Wall St. Rank hold PBH as of Q3 2016.

  • Turner Investments reported no remaining Prestige Consumer Healthcare position as of Q3 2016 after selling out during the quarter.
  • Turner Investments sold 23,000 Prestige Consumer Healthcare shares in Q3 2016, an estimated $1.27M.
  • Turner Investments first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 8 quarters.
  • Turner Investments's Prestige Consumer Healthcare position peaked at $11.9M in Q4 2013.
  • 243 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2016.

Based on Turner Investments's 13F filing for Q3 2016, filed 14 Nov 2016.